secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001005286-24-000056
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore changes executive incentive from cash to stock for FY2024
------------------------------------------------------------------

- CFO John D. Morberg and James G. Hall will receive FY2024 incentive in fully vested, unrestricted shares instead of cash.
- Number of Bonus Shares equals cash incentive amount divided by fair market value on determination date.
- Shares issued under 2019 Stock Incentive Plan; if insufficient reserves, pro rata issuance with contingent shareholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000056/0001005286-24-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000056/lndc-20240501.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer